{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:41:55Z","timestamp":1789864915033,"version":"4.0.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001346","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T21:41:01Z","timestamp":1318369261000},"page":"e1346","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria"],"prefix":"10.1371","volume":"5","author":[{"given":"Frank O.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Eigege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Miri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonsus","family":"Kal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Umaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davou","family":"Pam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay J.","family":"Rakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohanna","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Danboyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bako","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon E.","family":"Adelamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Ogah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danjuma","family":"Goshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Kehinde","family":"Oyenekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Craig","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisa A.","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Jiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"ref1","first-page":"3","article-title":"Lymphatic filariasis. Fourth report of the WHO Expert Committee on Filariasis.","volume":"702","year":"1984","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref2","article-title":"Preventative chemotherapy in human helminthiasis.","year":"2006"},{"key":"ref3","article-title":"Guidelines for certifying lymphatic filariasis elimination (including discussion of critical issues and rationale).","year":"1999"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1179\/000349802125002374","article-title":"Lymphatic filariasis elimination: progress in global programme development.","volume":"96","author":"DH Molyneux","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: Treatment, control and elimination.","volume":"61","author":"EA Ottesen","year":"2006","journal-title":"Adv Parasitol"},{"key":"ref6","first-page":"365","article-title":"Global programme to eliminate lymphatic filariasis.","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"ref7","year":"2011"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14656566.6.2.179","article-title":"Treatment strategies underpinning the global programme to eliminate lymphatic filariasis.","volume":"6","author":"JO Gyapong","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"ref9","first-page":"1","article-title":"Recommendations of the International Task Force for Disease Eradication.","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"key":"ref10","article-title":"Building Partnerships for Lymphatic Filariasis.","year":"1999"},{"key":"ref11","first-page":"333","article-title":"Global programme to eliminate lymphatic filariasis.","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(04)00973-9","article-title":"Mathematical modelling and the control of lymphatic filariasis.","volume":"4","author":"E Michael","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"ref13","first-page":"401","article-title":"Sixth meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, Geneva, Switzerland, 20\u201323 September 2005.","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3156.2005.01542.x","article-title":"Editorial: Global elimination of lymphatic filariasis: fact or fantasy?","volume":"11","author":"JO Gyapong","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","article-title":"Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.","volume":"79","author":"D Kyelem","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1371\/journal.pntd.0000696","article-title":"Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.","volume":"4","author":"PE Simonsen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","article-title":"Preparing and implementing a national plan to eliminate lymphatic filariasis","year":"2000"},{"key":"ref18","article-title":"Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level.","year":"2005"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0035-9203(00)90431-0","article-title":"Mapping and estimating the population at risk from lymphatic filariasis in Africa.","volume":"94","author":"SW Lindsay","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.2009.80.691","article-title":"Nigeria&apos;s war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots.","volume":"80","author":"NA Njepuome","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4269\/ajtmh.2010.10-0140","article-title":"Nigeria&apos;s triumph: dracunculiasis eradicated.","volume":"83","author":"ES Miri","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","first-page":"23","article-title":"African Programme for Onchocerciasis Control - report of the sixth meeting of national task forces, October 2009.","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0001-706X(95)00116-V","article-title":"Community-based ivermectin distributors: onchocerciasis control at the village level in Plateau State, Nigeria.","volume":"61","author":"F Richards Jr","year":"1996","journal-title":"Acta Trop"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1080\/00034983.1998.11813375","article-title":"Problems and perspectives of managing an onchocerciasis control programme: a case study from Plateau state, Nigeria.","volume":"92","author":"ES Miri","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1080\/00034983.1998.11813370","article-title":"Human onchocerciasis: current assessment of the disease burden in Nigeria by rapid epidemiological mapping.","volume":"92","author":"EI Gemade","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2002.67.266","article-title":"Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.","volume":"67","author":"DR Hopkins","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2883-4-6","article-title":"Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity.","volume":"4","author":"FO Richards Jr","year":"2005","journal-title":"Filaria J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/136485905X19838","article-title":"Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.","volume":"99","author":"FO Richards Jr","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pt.2006.12.001","article-title":"Diagnostic tools for filariasis elimination programs.","volume":"23","author":"GJ Weil","year":"2007","journal-title":"Trends Parasitol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4269\/ajtmh.2003.68.643","article-title":"Rapid assessment for lymphatic filariasis in central Nigeria: a comparison of the immunochromatographic card test and hydrocele rates in an area of high endemicity.","volume":"68","author":"A Eigege","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","article-title":"Operational guidelines for rapid mapping of Bancroftian filariasis in Africa.","year":"2000"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","article-title":"The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis.","volume":"13","author":"GJ Weil","year":"1997","journal-title":"Parasitol Today"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1179\/000349802125000646","article-title":"The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC).","volume":"96","author":"UV Amazigo","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1179\/136485908X337436","article-title":"The African Programme for Onchocerciasis Control (APOC).","volume":"102","author":"U Amazigo","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/136485906X86266","article-title":"Urban lymphatic filariasis in central Nigeria.","volume":"100","author":"A Terranella","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4269\/ajtmh.2001.65.108","article-title":"The Carter Center&apos;s assistance to river blindness control programs: establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents.","volume":"65","author":"FO Richards Jr","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4269\/ajtmh.2007.77.593","article-title":"A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of Lymphatic Filariasis.","volume":"77","author":"HA Farid","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.","volume":"68","author":"SI McLaughlin","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3201\/eid1304.061063","article-title":"Endpoints for lymphatic filariasis programs.","volume":"13","author":"CA Grady","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(06)68426-2","article-title":"Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.","volume":"367","author":"RM Ramzy","year":"2006","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pt.2004.11.011","article-title":"Determinants of the eradicability of filarial infections: a conceptual approach.","volume":"21","author":"HP Duerr","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref42","first-page":"358","article-title":"Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.","volume":"79","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/164.4.814","article-title":"Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.","volume":"164","author":"GJ Weil","year":"1991","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea.","volume":"347","author":"MJ Bockarie","year":"2002","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pt.2009.03.013","article-title":"The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis.","volume":"25","author":"EM Pedersen","year":"2009","journal-title":"Trends Parasitol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.ento.54.110807.090626","article-title":"Role of vector control in the global program to eliminate lymphatic filariasis.","volume":"54","author":"MJ Bockarie","year":"2009","journal-title":"Annu Rev Entomol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4269\/ajtmh.2004.70.63","article-title":"The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.","volume":"70","author":"PE Simonsen","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/657063","article-title":"Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.","volume":"51","author":"B Dembele","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1179\/000349802125002509","article-title":"Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis.","volume":"96","author":"G Pichon","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2883-5-10","article-title":"The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis.","volume":"5","author":"TR Burkot","year":"2006","journal-title":"Filaria J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.","volume":"3","author":"L Diawara","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/136485908X278810","article-title":"Missed treatment opportunities for schistosomiasis mansoni, in an active programme for the treatment of urinary schistosomiasis in Plateau and Nasarawa states, Nigeria.","volume":"102","author":"J Gutman","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2471\/BLT.06.029652","article-title":"Integration of mass drug administration programmes in Nigeria: The challenge of schistosomiasis.","volume":"84","author":"FO Richards Jr","year":"2006","journal-title":"Bull World Health Organ"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T10:00:38Z","timestamp":1560765638000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001346"}},"subtitle":[],"editor":[{"given":"John Owusu","family":"Gyapong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001346","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}